Related Experiment Videos
[Effects of prostadyn sabale capsules on chronic prostatitis]
Tianpeng Wu1, Xiaobin Zhang, Rongyang Wu
1Department of Urology, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China. WTP1682002@yahoo.com.cn
Zhonghua Nan Ke Xue = National Journal of Andrology
|June 12, 2004
Summary
Prostadyn sabale capsules show good effects in treating chronic prostatitis (CP). This study found an 82.7% total effectiveness rate with no observed side effects.
Area of Science:
- Urology
- Pharmacology
Context:
- Chronic prostatitis (CP) affects a significant patient population.
- Current treatment options for CP have limitations.
Purpose:
- To evaluate the efficacy and safety of Prostadyn sabale capsules for treating chronic prostatitis (CP).
Summary:
- 125 CP patients were treated with Prostadyn sabale capsules (320 mg twice daily).
- Treatment outcomes were assessed using the NIH Chronic Prostatitis Symptom Index (NIH-CPSI) and expressed prostatic secretions (EPS) analysis.
- Overall effectiveness reached 82.7%, with cure rates of 25.8% (Category II), 16.0% (Category IIIA), and 21.1% (Category IIIB).
Impact:
- Prostadyn sabale capsules demonstrate a favorable safety profile with no reported side effects.
- These findings suggest Prostadyn sabale capsules as a potentially effective therapeutic option for chronic prostatitis.